Infection of gastric mucosa by Helicobacter pylori induces an inflammatory response with increased levels of proinflammatory cytokines. Among them, tumor necrosis factor (TNF)-a, interleukin (IL)-1b and IL-6 induce the activation of signaling pathways that regulate genes expression, such as MUC2 and MUC4 intestinal mucins ectopically detected in gastric tumors. This study evaluated if the predominant inflammatory cell type correlates with MUC2 and MUC4 expression in human intestinal gastric tumors (n ¼ 78). In addition, we analyzed the regulatory effects of the associated inflammatory signaling pathways on their expression in gastric cancer cell lines, and in a mouse model with hyperactivated STAT3 signaling pathway. Tumors with predominant lymphoplasmocytic infiltrate (chronic inflammation), presented higher levels of MUC2 and were more differentiated than tumors with predominant polymorphonuclear infiltrate (acute inflammation). These differences can be attributed to specific cytokines, because TNF-a and IL-1b induced MUC2 but no MUC4 expression in gastric cancer cell lines. The two groups of tumors expressed similar levels of MUC4 that correlated with the expression of STAT3 transcription factor, implicated in the activation of genes through the IL-6 pathway. In gastric tissues from
Introduction
Helicobacter pylori infection is the major predisposing factor for the development of gastric adenocarcinomas (Peek and Crabtree, 2006) . The inflammatory response associated with the bacterial infection is characterized by the massive recruitment of polymorphonuclear and mononuclear cells, and, as a consequence, increased levels of proinflammatory cytokines such as interleukin (IL)-1b, tumor necrosis factor (TNF)-a, IL-6 and IL-8 are found in the stomach mucosa (Crabtree et al., 1991) . IL-1b and TNF-a can activate the signaling pathways mediated by the nuclear factor (NF)-kB transcription factor (Karin, 2006) , involved in tumor progression by the activation of anti-apoptotic (Yu and Jove, 2004) and angiogenesis related genes (Kimura et al., 2007) . The IL-6 cytokine family activates genes that can regulate gastric homeostasis through the SHP2/Erk and STAT1/ 3 pathways, on binding to gp130 receptor. To analyze the consequences of disrupting the balance between the two pathways, several mouse models have been developed. In this context, transgenic mice harboring a knock-in mutation in the gp130 receptor subunit develop spontaneous antral gastric tumors by 4 weeks of age as a consequence of increased STAT3 activation (Tebbutt et al., 2002; Jenkins et al., 2005) .
Mucins are high-molecular-weight glycoproteins that maintain epithelial integrity and lubricate and protect epithelial surfaces. In the normal mucosa, gastric mucins (MUC5AC, MUC6) are detected in a cell-specific expression pattern (de Bolos et al., 1995) , that is lost in gastric adenocarcinomas and during the first stages of the neoplastic transformation in which intestinal mucins, MUC2 and MUC4, can be detected (Reis et al., 1999; Lopez-Ferrer et al., 2000; Leung et al., 2002) . The activation of these intestinal mucin genes could be regulated by the inflammatory cytokines induced by the response associated with H. pylori colonization of the gastric mucosa. In this sense, we have recently shown that IL-6 induces the expression of MUC4, but not MUC2, through the activation of the gp130/STAT3 signaling pathway in gastric cancer cell lines in vitro (Mejias-Luque et al., 2008) . In addition, the presence of H. pylori has been associated with the upregulation of MUC2 in gastric cancer cell lines (Matsuda et al., 2008) .
The presence of specific inflammatory cell types characterizes the acute and chronic inflammation, and these different inflammatory cells determine specific patterns of cytokine expression. The predominant cells infiltrating the gastric mucosa in chronic inflammation are lymphocytes, plasma cells and macrophages; whereas in the acute or active inflammation the polymorphonuclear neutrophiles are the main infiltrating cells. To evaluate the implication of the inflammatory cells and the related signaling pathways in the expression of intestinal markers associated with gastric cancer, here we have classified a group (n ¼ 78) of intestinal gastric carcinomas according to their inflammatory score, chronic or acute, and we have analyzed the expression of the intestinal mucin genes (MUC2 and MUC4) and results have been related to specific clinicopathological characteristics of the patients. Tumors with chronic inflammation showed significantly higher levels of MUC2, that could be attributed to the presence of certain cytokines such as TNF-a or IL-1b, that are related to chronic inflammation (Sell and Max, 2001) , and that we show to induce MUC2 but no MUC4 in gastric cancer cell lines. Therefore, we have evaluated the expression of the intestinal mucins MUC2 and MUC4 in vitro by stimulating gastric cancer cell lines with different concentrations of these cytokines, and the associated signaling pathways have been analyzed.
We had earlier reported that MUC4 and no MUC2 expression was regulated by IL-6 through the gp130/ STAT3 pathway in gastric cancer cell lines (MejiasLuque et al., 2008) , for this reason in the two groups of tumors we have analyzed the expression STAT3 transcription factor associated with MUC4. Furthermore, to confirm the activation of the MUC4 intestinal mucin but not MUC2 through the gp130/STAT3 signaling pathway in vivo, the expression of Muc2, Muc4 and the gastric mucin Muc5AC has been examined in normal and tumor stomach samples from gp130 þ / þ , and transgenic gp130 Y757F/Y757F and gp130 Y757F/Y757F Stat3 À/ þ mice.
Results

Classification of the tumors by the inflammatory infiltrate
Two groups of intestinal gastric cancer samples were established according to the predominant cell type present in their inflammatory component: Lymphoplasmocytic (LP) group, with X50% of lymphoplasmocytic inflammatory infiltrate (n ¼ 53) corresponding to chronic inflammation; and polymorphonuclear (PMN) group with X50% of polymorphonuclear cells in the inflammatory component (n ¼ 25), which corresponds to acute or active inflammation ( Figure 1 ). The different number of tumors in each group indicated that chronic inflammation is most frequently associated with this tumor type.
Relation between clinical characteristics of the patients and inflammatory infiltrate
The most relevant clinical characteristics of the patients are shown in Table 1 .
Regarding the association between specific clinical features and the inflammatory cells infiltrating the tumors, it is remarkable that in the LP group 67.9% (36/53) of the tumors were well differentiated (grade I and II) and only 32.0% (17/53) were moderate or poorly differentiated; whereas in the PMN group, the number of well differentiated and poorly differentiated tumors was similar: 56.0% (14/25) and 44.0% (11/25), respectively. These data suggest a trend in the association between the inflammatory score of the gastric tumors and their histological grade.
No other relevant clinical characteristics were different between both groups of gastric tumors, as it is shown in Table 1 . Intestinal gastric cancer markers related to inflammation R Mejías-Luque et al
Expression patterns of the intestinal mucins MUC2 and MUC4 in human gastric tumors MUC2 and MUC4, that have been described to be ectopically expressed in intestinal gastric cancer and in the precursor phases of this tumor type (Lopez-Ferrer et al., 2000) were analyzed in the two groups of gastric cancer to detect if their expression could be related to the inflammatory characteristics of the tumor. MUC2 was expressed in 28.58 and 13.20% of the tumor cells, and 44 out of 53 and 19 out of 25 positive cases were found in the LP and PMN groups, respectively. These results indicated that in tumors with acute inflammatory infiltrate, that have predominance of polymorphonuclear cells, the levels of MUC2 positive cells were lower and this difference was statistically significant (P ¼ 0.029).
By contrast, no significant differences were found in the detection of MUC4: 20.75 and 24.40% of the cells and 40 out of 53 and 20 out of 25 of the tumors were positive for LP and PMN groups, respectively (P ¼ 0.472).
In summary, these data showed that tumors showing chronic inflammation (LP) expressed higher levels of MUC2 than tumors with acute inflammation (PMN) and were more differentiated, whereas no differences in the levels of MUC4 were detected. Results are shown in Figures 1a and b .
The association between the expression of MUC2 and MUC4 and the presence of H. pylori was also evaluated. (Figure 2a ). The levels of the intestinal mucin MUC4 were also analyzed after TNF-a and IL-1b stimulation, and no induction of its expression was observed (data not shown).
To further characterize MUC2 expression induced by TNF-a, MKN45 and NUGC-4 cells were treated with 70 ng/ml of TNF-a for different times. Maximum MUC2 mRNA levels were detected after 5 h treatment in MKN45 cells (Figure 2b ). In NUGC-4 cells, MUC2 expression was induced after 1-h TNF-a stimulation, and maximum levels were observed after 10-h treatment.
Protein levels of MUC2 were assessed in untreated and TNF-a-or IL-1b-stimulated cells (100 ng/ml) by immunocytochemistry. No MUC2 apomucin was detected in untreated MKN45 and NUGC-4 cells, and after 20-h TNF-a or IL-1b treatment, positive MKN45 and NUGC-4 cells were observed ( Figure 2c ). The levels of MUC2 apomucin were also analyzed by western blot in MKN45 cells, and 20-h treatment with TNF-a or IL-1b induced the expression of MUC2 (Figure 2d ).
TNF-a induces MUC2 expression through NF-kB pathway
To analyze whether the activation of MUC2 by cytokines associated with chronic inflammation occurred through the NF-kB signaling pathway, western blot against p-IkBa and IkBa was performed. After 10 min of TNF-a stimulation, phosphorylation of Ika was observed in MKN45 and NUGC-4 cells. As expected, a decrease in IkBa protein levels was detected after TNF-a treatment ( Figure 3a) .
To show the direct involvement of the NF-kB signaling pathway in the activation of MUC2 transcription, MKN45 cells were treated with panepoxydone, a specific inhibitor of IkBa phosphorylation. Phosphorylated IkBa was analyzed by western blot, and as expected, the cells treated with panepoxydone presented lower levels of IkBa phosphorylation ( Figure 3b ). MUC2 mRNA levels were also analyzed after 10-h and 20-h of TNF-a or TNF-a plus panepoxydone treatment. Decreased levels of MUC2 after TNF-a stimulation were observed in the cells incubated with panepoxydone ( Figure 3c ), indicating that the activation of MUC2 by TNF-a occurs through the NF-kB signaling pathway. Intestinal gastric cancer markers related to inflammation R Mejías-Luque et al 
Intestinal gastric cancer markers related to inflammation R Mejías-Luque et al
These results were confirmed by analyzing the levels of p65 by immunocytochemistry in MKN45 and NUGC-4 cells, in which p65 nuclear staining was only observed after TNF-a treatment. In contrast, GP220 cells that already express MUC2, presented constitutively activated p65 (Figure 3d ). Intestinal gastric cancer markers related to inflammation R Mejías-Luque et al
MUC2 and NF-kB expression in gastric tumors
The expression of MUC2 and p65 was analyzed in gastric adenocarcinomas (n ¼ 18). For p65, only p65 nuclear staining was considered as positive. The levels of p65 ranged from 2.5 to 35% of positive cells and, both MUC2 and p65 were detected in 13 out of 18 cases. To analyze the co-expression of p65 with MUC2, double labeling immunofluorescence was performed in gastric tumor samples (n ¼ 5) (Figure 3e ). MUC2 and p65 were co-expressed in gastric tumors, suggesting that MUC2 expression can be modulated by the NF-kB signaling pathway in vivo.
Detection of STAT3 transcription factor
In gastric cancer cell lines, we have recently reported that MUC4 was activated through STAT3 by the direct binding of the active form p-STAT3 to the MUC4 promoter (Mejias-Luque et al., 2008) .
The expression of STAT3 was evaluated in the two groups of stomach cancer tissues (n ¼ 48) as total STAT3 and activated p-STAT3. STAT3 was detected in the cytoplasm and focally in the nucleus of the tumor cells, whereas p-STAT3 staining was exclusively nuclear. STAT3 was expressed in 31.67 and 37.89% of the tumor cells, and in 20 out of 30 and 14 out of 18 tumor samples of the LP and PMN groups, respectively. The active form of STAT3, p-STAT3, was positive in 11.17% of the cells and in 17 out of 30 cases in the LP tumors, and in 9.87% and 12/18 in the PMN group. A weak negative correlation was found between the expression of MUC2 and STAT3 (r 2 ¼ À0.091), whereas MUC4 and STAT3 expression correlated positively (r 2 ¼ 0.145). These results are shown in Figure 4a , whereas the expression of MUC2 and MUC4 is shown in Figure 1b .
To asses the co-expression of STAT3 and MUC4, double immunofluorescence labeling was performed in selected tumor cases (n ¼ 5) in which both molecules had been detected earlier. Results indicated that STAT3 and MUC4 were co-detected in all the cases with different number of cells co-expressing both molecules, as it is shown in Figure 4b . Stat3 À/ þ mice were statistically significant (P ¼ 0.02 and P ¼ 0.042, respectively) ( Figure 5a ).
By immunohistochemistry, the intestinal mucin, Muc2 was absent from the gastric tissue, including the tumors, in all the three genotypes (data not shown), although the goblet cells of the duodenum were positive, showing that the immunohistochemical stain worked. Muc5AC gastric mucin was detected in the mucus-secreting cells of superficial epithelium in all the mice: wild-type, gp130
Y757F/Y757F
, and gp130 Y757F/Y757F Stat3 À/ þ as expected (Figure 5c ). The 14-week-old gp130 Y757F/Y757F mice had large stomach tumors that covered the whole antrum and part of the corpus. In these tumors, Muc5AC expression was decreased by 90% (Figure 5c ). The intestinal mucin, Muc4 was absent or very weakly expressed in the normal gastric epithelium of wild-type mice and in the hyperplastic gastric tissue of the mutant mice. In contrast, Muc4 was detected at varying levels in tumors from all the gp130 Y757F/Y757F mice (Figures 5b and c) . These data confirm the results obtained by quantitative RT-PCR.
The expression of p-STAT3 was also evaluated in the same mice stomach samples. Results showed a correlation between the expression of this transcription factor and Muc4. No nuclear detection of p-STAT3 was found in the gastric mucosa of wild-type mice, whereas the gp130 Y757F/Y757F mice expressed higher number of positive nuclei (Figure 5c ) than the gp130 Y757F/Y757F Stat3 À/ þ mice (data not shown).
Discussion
The inflammatory cells infiltrating the gastric mucosa as a response to H. pylori infection, can modulate the Intestinal gastric cancer markers related to inflammation R Mejías-Luque et al presence of specific cytokines (Peek and Crabtree, 2006) . These cytokines activate signaling pathways that regulate the expression of genes involved in the gastric carcinogenetic process. Among them, glycosylation enzymes, mucins and trefoil factors have been reported to be aberrantly expressed during the acquisition of an intestinal phenotype in gastric carcinogenesis. In this study, we report that MUC2 was significantly more detected in human gastric tumors showing chronic inflammation (lymphoplasmocytic cells) than in tumors with acute inflammation (polymorphonuclear cells).
By contrast, no differences were found in the expression of MUC4 or the transcription factor STAT3, which can activate MUC4, but not MUC2 (Mejias-Luque et al., 2008) . MUC2 is a secreted mucin than can be regulated through different pathways such as MAPK, NF-kB and Ras/MEK in colon cancer cells (Lee et al., 2002; Kim et al., 2004; Ahn et al., 2005) . Muc2 À/À mice present increased proliferation and migration and decreased apoptosis of intestinal epithelial cells and develop spontaneous tumors that progress to invasive carcinomas, suggesting a role for Muc2 in tumor suppression (Velcich et al., 2002) . Our results show that MUC2 is activated by IL-1b and TNF-a through the NF-kB signaling pathway in gastric cancer cells, and in addition, MUC2 is detected associated with the transcription factor p65 in gastric tumor samples.
MUC4 is a membrane-bound mucin that has been involved in tumor growth and metastasis through several mechanisms related to its cytoplasmic tail, which has been implicated in cell signaling events (reviewed in Chaturvedi et al., 2008) . The transcriptional induction of MUC4 by STAT3 agrees with the fact that no differences in MUC4/STAT3 detection were found in the two groups of tumors, suggesting that the initial acute inflammation should trigger the activation of the gp130/STAT3 signaling pathway, and this activation may promote the apparition of chronic inflammatory cells. The gp130 Y757F/Y757F mutant mice with inhibited SHP2-Ras-ERK signaling pathway, develop inflammation, athrophy, dysplasia and gastric tumors as a consequence of hyperactivated STAT3 (Tebbutt et al., 2002; Jenkins et al., 2005) . In this mutant mouse model, the levels of polymorphonuclear and mononuclear inflammatory cells infiltrating the gastric mucosa are increased when compared with the wild-type and gp130
mice, suggesting that the recruitment of infiltrating cells correlates with the amount of STAT3; and these mice also show higher IL-6 and IL-11 expression levels (Judd et al., 2006) . In this study, we have analyzed the expression of gastric (Muc5AC) and intestinal (Muc2 and Muc4) mucin genes in the stomach from gp130 þ / þ , gp130 Y757F/Y757F and gp130 Y757F/Y757F Stat3 À/ þ mice. The expression of Muc5AC is downregulated in the two mutant mice, whereas in the stomachs of the gp130 Y757F/Y757F only Muc4 is activated, and it is also slightly detected in the gp130 Y757F/Y757F Stat3 À/ þ mice. These data indicate again a correlation between the expression of STAT3 and Muc4, corroborating that MUC4 activation occurs through the gp130/STAT3 signaling pathway, as we have reported earlier in human gastric cancer cell lines (Mejias-Luque et al., 2008) , and suggest an active role of this signaling pathway in the regulation of genes associated with the gastric neoplastic transformation. In gastric cancer, the expression of molecules associated with this pathway has been related to a worse prognostic, to a VEGF over expression (Gong et al., 2005) , and to a shorter survival post-surgery (Yakata et al., 2007) . In addition, the activation of STAT3 and ERK 1/2 is increased in stomach samples of patients infected with H. pylori, and these increases are likely Intestinal gastric cancer markers related to inflammation R Mejías-Luque et al driven in an IL-6-dependent manner, whereas IL-11 is upregulated in gastric adenocarcinoma regulating epithelial cell turnover (Jackson et al., 2007) . The inflammatory cells infiltrating human colorectal tumors have been recently characterized in a large cohort of samples, and in these tumors the type, density, and location of the immune cells have a prognostic value superior to the histopathological methods currently used to stage colorectal cancer (Galon et al., 2006) . Although a larger number of samples is needed to be evaluated, here we have observed that the classification of gastric tumors according to the predominant infiltrating inflammatory cells in the two groups, chronic (LP) or acute/active (PMN), can be correlated with their histological grade: Tumors with lymphoplasmocytic infiltration are more differentiated (grade I and II) and this characteristic has been associated with a better prognostic. Furthermore, these tumors present higher levels of MUC2 that has been associated with a more favorable outcome in gastric cancer (Senapati et al., 2008) . Together these data suggest that inflammatory cells infiltrating the intestinal-type gastric tumors can modulate the transdifferentiation process by regulating signaling pathways implicated in the expression of specific genes involved in the gastric carcinogenesis process.
Materials and methods
Human tissue samples: histological and clinico-pathological characteristics of the patients Stomach cancer tissue samples (n ¼ 78) were obtained from the paraffin-embedded tissue bank of the Servei d'Anatomia Patolo`gica at the Hospital del Mar (Barcelona, Spain). The study was approved by the ethics committee of the institution (IMIM-Hospital del Mar). Paraffin-embedded tissues were processed in 4 mm sections and hematoxylin-eosin stained to be used for diagnostic purposes and classification by the inflammatory component.
Mouse gastric tissues
Stomachs from 14-week-old mice of gp130 (Tebbutt et al., 2002; Jenkins et al., 2005) were harvested. Three of each mice group were processed for RNA extraction, and the rest were fixed over night in 4% paraformaldehyde and paraffin embedded. Stomachs from wild-type mice were normal, the gp130 Y757F/Y757F mice developed large gastric tumors and a high hyperplasic response, and the gp130
mice presented an intermediate phenotype with mainly normal epithelium and small adenomas, as it has been reported earlier (Judd et al., 2004) .
Antibodies and immunohistochemical assays
To detect human intestinal mucins, monoclonal antibody LDQ10, recognizing MUC2, was used as ascites at 1/500 dilution, and rabbit polyclonal antibody anti-MUC4 was used at 1/80 dilution. The characterization and specificity of these antibodies had been reported earlier (Lopez-Ferrer et al., 2000; Lopez-Ferrer and de Bolos, 2002) . Indirect immunoperoxidase technique was performed on paraffin-embedded sections as described (Lopez-Ferrer et al., 2000) . For STAT3 and p-STAT3 staining anti-STAT3 and anti-p-STAT3 (Tyr705) antibodies were purchased from Cell Signaling (Danvers, MA, USA) and used following manufacturer's instructions. Anti-p65 antibody was obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). For p65 detection slides were boiled for 15 min in 10 mM sodium citrate pH 6. After washing, slides were blocked using 5% horse serum diluted in phosphate-buffered saline-1% bovine serum albumin for 1 h. p65 antibody diluted at 1/2000 in phosphate-buffered saline-1% bovine serum albumin was incubated o/n at 4 1C. Samples were rinsed and incubated with anti-rabbit EnVision-HRP for 30 min. Sections were developed using DAB (Dako, Carpinteria, CA, USA). For mouse mucins detection the antibodies used were: the polyclonal antibodies MM2-2 for Muc2 (Heazlewood et al., 2008 ) (a kind gift from Professor M McGuckin, Brisbane, Australia) and hHA1-B-1 against the C-terminal sequence of Muc4 (a kind gift from Professor K Carraway, Miami, FL, USA) and the 45M1 monoclonal antibody recognizing Muc5AC (Lidell et al., 2008) . The specificity of these antibodies on mouse tissues had been described earlier (Linden et al., 2008) . Antigen retrieval used for the detection of the different antibodies was either: (1) Intestinal sections were used as positive controls for MUC2 and MUC4 human and mice antibodies.
Cell culture and treatments MKN45 and NUGC-4 human gastric cancer cell lines were obtained from ATCC, and GP220 cells were established in Dr Sobrinho-Simo˜es' laboratory (Gartner et al., 1996) . All cell lines were maintained at 37 1C in CO 2 atmosphere in 10% fetal calf serum supplemented Dulbecco's modified Eagle's medium. For TNF-a or IL-1b treatment (PreproTech EC, London, UK), semi-confluent cells were rinsed in phosphate-buffered saline and incubated for 20 h with 40 ng/ml, 70 ng/ml or 100 ng/ml of the cytokines diluted in Dulbecco's modified Eagle's medium. For time course experiments, cells were incubated with 70 ng/ml TNF-a for 10 min, 1 h, 5 h, 10 h and 20 h. To prevent NF-kB activation, cells were incubated with 70 ng/ml or 100 ng/ml of TNF-a in combination with 5 mg/ml of panepoxydone (Alexis Biochem., Lausanne, Switzerland) for 10 min, 10 or 20 h.
Quantitative RT-PCR Total RNA extraction was carried out from control and TNFa or IL-1b-stimulated cells using GenElute Mammalian Total RNA Miniprep kit (Sigma-Aldrich, St Louis, MO, USA). After rDNAse I (Ambion, Austin, TX, USA) treatment, quantitative determination of MUC2 mRNA levels was performed in triplicate using QuantiTect SYBR green RT-PCR (Qiagen GmbH, Germany). MUC2 was amplified by primers 5 0 -CTT CGA CGG ACT CTA CTA CAG C-3 0 (sense) and 5 0 -CTT TGG TGT TGT TGC CAA AC-3 0 (antisense) (Lopez-Ferrer et al., 2001) . Hypoxanthine-guanine phosphoribosyl transferase mRNA (GeneCards database, Xennex, Cambridge, MA, USA, NCBI36:X) was analyzed as an internal control by using oligonucleotides 5 0 -GGCCAGACTTTG TTGGATTTG-3 0 (sense) and 5 0 -TGCGCTCATCTTAGG CTTTGT-3 0 (antisense). RT-PCR and data collection were performed using the ABI Prism 7900HT system (Applied Biosystems, Foster City, CA, USA). All quantifications were normalized to the endogenous control (hypoxanthine-guanine phosphoribosyl transferase). Two independent experiments were performed.
Total RNA was extracted from snap-frozen mouse tissues using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. To eliminate any contaminating genomic DNA, on-column DNase digestion was performed using the RNeasy Mini Kit (Qiagen, Valencia, CA, USA). Complementary DNA was prepared from 1 mg of total RNA using the SuperScript III First-Strand Synthesis System (Invitrogen) following manufacturer's instructions. Quantitative RT-PCR (Q-PCR) gene expression analyses were performed on triplicate samples with SYBR Green (Invitrogen) using the 7900HT Fast RT-PCR System (Applied Biosystems, Foster City, CA, USA) over 40 cycles (95 1C/ 15 s, 60 1C/1 min), after an initial denaturation step at 95 1C/ 10 min. Primers to specifically amplify mouse 18S were used to normalize complementary DNA concentrations of target genes. The Muc4/18S Q-PCR was carried out using TaqMan primer/probe sets (ABI), and the Muc2/18S Q-PCR was performed using SYBR Green with the following primers: 18S forward 5 0 -GTAACCCGTTGAACCCCATT-3 0 18S reverse 5 0 -CCATCCAATCGGTAGTAGCG-3 0 Muc2 forward 5 0 -CCCA GAAGGGACTGTGTATG-3 0 Muc2 reverse 5 0 -TGCAGACA CACTGCTCACA-3 0 . Data acquisition and analyses were performed using the Sequence Detection System Version 2.3 software (Applied Biosystems).
Cell lysates and western blot analysis
Cytoplasmic cell extracts were obtained for MUC2 detection by lysing the cells in 50 mM Tris pH8, 62.5 mM ethylenediaminetetraacetic acid and 1% Triton X-100 lysis buffer. Western blot was performed on 2% sodium dodecyl sulfateagarose gels as reported earlier (Piessen et al., 2007) . LDQ10 antibody was incubated for 2 h and bound secondary antibody was detected using the ECL western blotting substrate (Pierce, Rockford, IL, USA).
For IkBa and p-IkBa detection cellular pellets were solubilized in 2X sodium dodecyl sulfate gel sample buffer (20 mM dithiothreitol, 6% sodium dodecyl sulfate, 0.25 M TrisHCl pH 6.8, 10% glycerol and bromophenol blue) and sonicated using three bursts of 10 s each. Lysates were boiled at 95 1C for 5 min and immediately cooled on ice. Protein extracts were electrophoresed on 10% SDS-polyacrylamide gels. Separated proteins were blotted onto nitrocellulose membranes (Protran, Dassel), blocked for 1 h at RT, and incubated o/n with the specific primary antibodies following manufacturer's instructions (Cell Signaling). Bound secondary antibody was detected using ECL western blotting substrate.
Double labeling immunofluorescence
After antigen retrieval (10 mM sodium citrate, pH 6), samples were blocked for 1 h in 5% horse serum diluted in phosphatebuffered saline-Triton and anti-STAT3 and anti-MUC4 antibodies were incubated o/n at 4 1C. Slides were rinsed and incubated for 2 h with anti-mouse Alexa 488 and anti-Rabbit Alexa 546 antibodies and nuclei were stained with Hoechst, Sigma-Aldrich. For p65/MUC2 detection, samples were incubated o/n at 4 1C with anti-p65 antibody. Slides were successively incubated with anti-rabbit Cy3, LDQ10, and antimouse Alexa 488. After antibody incubation, samples were rinsed and mounted using Fluoromount reagent (Southern Biotech, Birmingham, AL, USA).
Statistical analysis
The association between the expression of the different molecular markers and the inflammatory score of the samples was evaluated using Mann-Whitney U-test or Student's t-test for continuous variables and Pearson's w 2 test for categorical variables. Positive (r 2 40) or negative (r 2 o0) correlations were established using the Spearman's rho correlation coefficient (r 2 ). Statistical analysis was performed using SPSS 15.0 (SPSS Inc., Chicago, IL, USA).
Statistical significance was established when Pp0.05.
